UPL Limited (NSE:UPL) — Market Cap & Net Worth

$5.86 Billion USD  · Rs541.83 Billion INR  · Rank #3231

Market Cap & Net Worth: UPL Limited (UPL)

UPL Limited (NSE:UPL) has a market capitalization of $5.86 Billion (Rs541.83 Billion) as of May 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #3231 globally and #146 in its home market, demonstrating a -1.84% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying UPL Limited's stock price Rs641.85 by its total outstanding shares 844169318 (844.17 Million). Analyse UPL Limited cash conversion from operations to see how efficiently the company converts income to cash.

UPL Limited Market Cap History: 2015 to 2026

UPL Limited's market capitalization history from 2015 to 2026. Data shows growth from $2.43 Billion to $5.86 Billion (7.61% CAGR).

Index Memberships

UPL Limited is a constituent of 9 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
NIFTY COMMODITIES
CNXCMDT
$699.34 Billion 0.84% #24 of 30
NIFTY MIDCAP 100
NIFMDCP100
$519.63 Billion 1.13% #48 of 100
NIFTY100 EQUAL WEIGHT
NIFTY100EW
$1.79 Trillion 0.33% #66 of 99
NIFTY 200
NIFTY200
$2.56 Trillion 0.23% #122 of 200
NIFTY 500
NIFTY500
$3.11 Trillion 0.19% #134 of 500
NIFTY ALHPA 50
NIFTYALI
$341.59 Billion 1.72% #17 of 47
NIFTY MIDCAP 150
NIFTYMIDCAP150
$695.80 Billion 0.84% #57 of 150
NIFTY TOTAL MARKET
NIFTYTOTALMKT
$3.20 Trillion 0.18% #132 of 750
NIFTY MIDCAP 50
NIMDCP50
$293.61 Billion 2.00% #30 of 50

Weight: UPL Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

UPL Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how UPL Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.02x

UPL Limited's market cap is 0.02 times its annual revenue

Industry average: 0.07x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.81x

UPL Limited's market cap is 0.81 times its annual earnings

Industry average: 7.30x Lower than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $3.62 Billion $138.71 Billion $9.40 Billion 0.03x 0.38x
2017 $4.30 Billion $161.24 Billion $17.27 Billion 0.03x 0.25x
2018 $4.33 Billion $171.41 Billion $20.22 Billion 0.03x 0.21x
2019 $5.04 Billion $218.37 Billion $14.91 Billion 0.02x 0.34x
2020 $4.07 Billion $354.78 Billion $17.76 Billion 0.01x 0.23x
2021 $6.61 Billion $384.18 Billion $28.71 Billion 0.02x 0.23x
2022 $6.42 Billion $459.71 Billion $36.26 Billion 0.01x 0.18x
2023 $5.35 Billion $531.34 Billion $35.70 Billion 0.01x 0.15x
2024 $4.57 Billion $425.99 Billion -$12.00 Billion 0.01x N/A
2025 $7.26 Billion $466.37 Billion $8.97 Billion 0.02x 0.81x

Competitor Companies of UPL by Market Capitalization

Companies near UPL Limited in the global market cap rankings as of May 4, 2026.

Key companies related to UPL Limited by market ranking:

  • Corteva Inc (NYSE:CTVA): Ranked #487 globally with a market cap of $53.89 Billion USD.
  • Nutrien Ltd (TO:NTR): Ranked #742 globally with a market cap of $35.75 Billion USD ( CA$49.42 Billion CAD).
  • Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #868 globally with a market cap of $30.42 Billion USD ( CN¥207.91 Billion CNY).
  • CF Industries Holdings Inc (NYSE:CF): Ranked #1580 globally with a market cap of $15.33 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#487 Corteva Inc NYSE:CTVA $53.89 Billion $80.85
#742 Nutrien Ltd TO:NTR $35.75 Billion CA$102.24
#868 Qinghai Salt Lake Industry Co.Ltd SHE:000792 $30.42 Billion CN¥39.29
#1580 CF Industries Holdings Inc NYSE:CF $15.33 Billion $122.69

UPL Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, UPL Limited's market cap moved from $2.43 Billion to $ 5.86 Billion, with a yearly change of 7.61%.

Year Market Cap Change (%)
2026 Rs5.86 Billion -19.28%
2025 Rs7.26 Billion +58.71%
2024 Rs4.57 Billion -14.53%
2023 Rs5.35 Billion -16.65%
2022 Rs6.42 Billion -2.80%
2021 Rs6.61 Billion +62.15%
2020 Rs4.07 Billion -19.25%
2019 Rs5.04 Billion +16.54%
2018 Rs4.33 Billion +0.66%
2017 Rs4.30 Billion +18.84%
2016 Rs3.62 Billion +48.95%
2015 Rs2.43 Billion --

End of Day Market Cap According to Different Sources

On May 4th, 2026 the market cap of UPL Limited was reported to be:

Source Market Cap
Yahoo Finance $5.86 Billion USD
MoneyControl $5.86 Billion USD
MarketWatch $5.86 Billion USD
marketcap.company $5.86 Billion USD
Reuters $5.86 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About UPL Limited

NSE:UPL India Agricultural Inputs
Market Cap
$5.86 Billion
Rs541.83 Billion INR
Market Cap Rank
#3231 Global
#146 in India
Share Price
Rs641.85
Change (1 day)
-0.35%
52-Week Range
Rs567.95 - Rs805.35
All Time High
Rs816.77
About

UPL Limited, together with its subsidiaries, manufactures and sells pesticides, insecticides, and micronutrients in India, Brazil, the United States, the United Kingdom, and internationally. It operates in three segments: Crop Protection, Seeds, and Non-Agro. The company offers herbicides, fungicides, insecticides, acaricides, seed treatment, adjuvants, bio-solutions, public health products, fumi… Read more